Improving Outcomes for Patients with NF1
Read about Philip Moss who participated in an NCI clinical trial led by Brigitte Widemann that is showing promise in treating children with NF1.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1124707.htm
- Syndication ID: 19918
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:17 PM
- Date Syndication Updated: Wednesday, August 25, 2021 at 09:13 AM
Embed Code Snippet
To get the embed code snippet please Login.
